|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$86,043,464 |
|
|
Indirect Value
|
$13,186,326,474 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,272,369,938 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
9
|
6
|
Stock
price went up :
|
0
|
6
|
Stock
price went down : |
9
|
0
|
|
|
|
Gain/Loss Ratio : |
-9.0
|
6.0
|
Percentage
Gain/Loss : |
-27.9%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 47 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2008-02-07 |
4 |
B |
$9.00 |
$7,371 |
I/I |
819 |
143,418 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-07 |
4 |
B |
$9.00 |
$873 |
I/I |
97 |
363,765 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-08 |
4 |
B |
$8.94 |
$807,257 |
I/I |
89,682 |
7,602,426 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-08 |
4 |
B |
$8.94 |
$182,205 |
I/I |
20,242 |
3,859,485 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-08 |
4 |
B |
$8.94 |
$36 |
I/I |
4 |
476,485 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-08 |
4 |
B |
$9.00 |
$2,143 |
I/I |
238 |
476,481 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-08 |
4 |
B |
$8.94 |
$25,672 |
I/I |
2,852 |
146,270 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-08 |
4 |
B |
$8.94 |
$3,042 |
I/I |
338 |
364,103 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-11 |
4 |
B |
$9.06 |
$933 |
I/I |
103 |
476,588 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-11 |
4 |
B |
$9.06 |
$10,975 |
I/I |
1,212 |
147,482 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-11 |
4 |
B |
$9.06 |
$6,547 |
I/I |
723 |
364,826 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-11 |
4 |
B |
$9.06 |
$345,119 |
I/I |
38,112 |
7,640,538 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-11 |
4 |
B |
$9.06 |
$77,885 |
I/I |
8,601 |
3,868,086 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-12 |
4 |
B |
$7.98 |
$247 |
I/I |
31 |
476,619 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-12 |
4 |
B |
$7.98 |
$2,889 |
I/I |
362 |
147,844 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-12 |
4 |
B |
$7.98 |
$34,337 |
I/I |
4,302 |
3,872,388 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-12 |
4 |
B |
$7.98 |
$91,589 |
I/I |
11,475 |
7,652,013 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-12 |
4 |
B |
$7.98 |
$439 |
I/I |
55 |
364,881 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-13 |
4 |
B |
$7.93 |
$816 |
I/I |
103 |
476,722 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-13 |
4 |
B |
$7.93 |
$9,661 |
I/I |
1,219 |
149,063 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-13 |
4 |
B |
$7.93 |
$114,090 |
I/I |
14,396 |
3,886,784 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-13 |
4 |
B |
$7.93 |
$304,356 |
I/I |
38,404 |
7,690,417 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-13 |
4 |
B |
$7.93 |
$1,434 |
I/I |
181 |
365,062 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-14 |
4 |
B |
$8.06 |
$2,665 |
I/I |
330 |
477,052 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-14 |
4 |
B |
$8.06 |
$31,668 |
I/I |
3,922 |
152,985 |
2.25 |
- |
|
1397 Records found
|
|
Page 47 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|